Mayersohn Joel David 5
5 · QSAM Biosciences, Inc. · Filed Feb 16, 2021
Insider Transaction Report
Form 5
Mayersohn Joel David
Director
Transactions
- Award
Options to buy common stock
2020-01-06+40,000→ 40,000 totalExercise: $0.50From: 2020-01-06Exp: 2030-01-06→ COMMON STOCK (40,000 underlying) - Conversion
COMMON STOCK
2020-09-30$0.22/sh+331,834$73,003→ 371,594 total - Award
COMMON STOCK
2020-12-17$0.22/sh+96,782$21,292→ 468,376 total
Holdings
- 37,840
Options to buy common stock
Exercise: $0.50From: 2018-12-01Exp: 2028-12-01→ COMMON STOCK (37,840 underlying)
Footnotes (2)
- [F1]Shares acquired upon conversion of promissory note at a conversion price of $0.22 per share.
- [F2]Shares acquired upon conversion of accured directors fees at a conversion price of $0.22 per share.